Daxor
8 hedge funds and large institutions have $2.1M invested in Daxor in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
20% more capital invested
Capital invested by funds: $1.75M → $2.1M (+$352K)
0.03% more ownership
Funds ownership: 6.14% → 6.17% (+0.03%)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.6K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$9.66K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.16K |
| 3 |
Renaissance Technologies
New York
|
-$2.21K |
| 4 |
Morgan Stanley
New York
|
-$2.08K |
DXR Hedge Fund Activity: Q1 2014 in Review
8 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2014, worth a combined $2.1M — up 20% from $1.75M a quarter earlier.
Fund positioning in DXR was balanced in Q1 2014: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $28.6K. The largest seller was UBS, cutting an estimated $9.66K.
- 8 institutional investors held Daxor (DXR) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $2.1M of Daxor stock for Q1 2014, up 20% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q1 2014 and 1 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q1 2014 was Vanguard Group, an estimated $28.6K added.
- The largest Daxor seller in Q1 2014 was UBS, an estimated $9.66K sold.
Based on aggregated 13F filings for Q1 2014.